HFM Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.1K Buy
254
+10
+4% +$3.71K 0.03% 40
2026
Q1
$71.6K Sell
244
-9
-4% -$2.96K 0.03% 42
2025
Q4
$88.4K Buy
253
+12
+5% +$4.05K 0.03% 41
2025
Q3
$77.9K Sell
241
-1
-0.4% -$311 0.03% 40
2025
Q2
$94K Buy
242
+4
+2% +$1.61K 0.04% 33
2025
Q1
$103K Buy
+238
New +$95.5K 0.05% 27

Other funds holding ELV

HFM Investment Advisors's ELV Position: Q2 2026 in Review

HFM Investment Advisors increased its Elevance Health (ELV) stake by 4.1% in Q2 2026, buying an estimated $3.71K and bringing the position to 254 shares worth $98.1K. The position accounts for 0.03% of the portfolio, ranked #40.

HFM Investment Advisors first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. The position peaked at $103K in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • HFM Investment Advisors held 254 shares of Elevance Health worth $98.1K as of Q2 2026.
  • HFM Investment Advisors bought 10 Elevance Health shares in Q2 2026, an estimated $3.71K.
  • Elevance Health made up 0.03% of HFM Investment Advisors's portfolio in Q2 2026, its #40 holding.
  • HFM Investment Advisors first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • HFM Investment Advisors's Elevance Health position peaked at $103K in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.